» Articles » PMID: 6732227

Pharmacokinetics of Vancomycin in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis

Overview
Specialty Pharmacology
Date 1984 May 1
PMID 6732227
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The pharmacokinetics of vancomycin were studied in four patients on continuous ambulatory peritoneal dialysis. After a single intravenous infusion of 10 mg/kg of total body weight, multiple blood, urine, and dialysate samples were collected during a 72-h evaluation period. The steady-state volume of distribution was 0.73 +/- 0.07 (mean +/- standard deviation) liters/kg with a beta half-life of 90.2 +/- 24.2 h. The continuous ambulatory peritoneal dialysis clearance of vancomycin was 1.35 +/- 0.35 ml/min, and the serum clearance was 6.4 +/- 1.1 ml/min. Peritoneal dialysate concentrations of vancomycin were rapidly attained after the intravenous infusion and averaged 2.2 +/- 0.7 mg/liter throughout the 72-h observation period. A loading dose of 23 mg/kg followed by a maintenance dose of 17 mg/kg every 7 days should attain and maintain therapeutic serum and dialysate concentrations. More frequent dosing may be necessary for less susceptible organisms.

Citing Articles

Two Innovative Approaches to Optimize Vancomycin Dosing Using Estimated AUC after First Dose: Validation Using Data Generated from Population PK Model Coupled with Monte-Carlo Simulation and Comparison with the First-Order PK Equation Approach.

Liu Q, Huang H, Xu B, Li D, Liu M, Shaik I Pharmaceutics. 2022; 14(5).

PMID: 35631590 PMC: 9147553. DOI: 10.3390/pharmaceutics14051004.


Vancomycin Intoxication and Cefepime-induced Encephalopathy Treated by Abdominal Drainage of Massive Ascites in Addition to Online Hemodiafiltration.

Taniguchi T, Inoue Y, Itoh M, Tomita M, Kamata T, Iehara N Intern Med. 2021; 60(11):1737-1742.

PMID: 33431732 PMC: 8222134. DOI: 10.2169/internalmedicine.6233-20.


Vancomycin in peritoneal dialysis: Clinical pharmacology considerations in therapy.

Lam E, Lien Y, Kraft W, Piraino B, Vozmediano V, Schmidt S Perit Dial Int. 2020; 40(4):384-393.

PMID: 32065053 PMC: 9847573. DOI: 10.1177/0896860819889774.


Effect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting technique.

Guay D, Gilliland S, Rodvold K, Rotschafer J Antimicrob Agents Chemother. 1993; 37(3):436-40.

PMID: 8460912 PMC: 187689. DOI: 10.1128/AAC.37.3.436.


Vancomycin disposition during continuous ambulatory peritoneal dialysis: a pharmacokinetic analysis of peritoneal drug transport.

Rogge M, Johnson C, Zimmerman S, Welling P Antimicrob Agents Chemother. 1985; 27(4):578-82.

PMID: 4004194 PMC: 180099. DOI: 10.1128/AAC.27.4.578.


References
1.
Eykyn S, Phillips I, Evans J . Vancomycin for staphylococcal shunt site infections in patients on regular haemodialysis. Br Med J. 1970; 3(5714):80-2. PMC: 1701050. DOI: 10.1136/bmj.3.5714.80. View

2.
Morris A, Bilinsky R . Prevention of staphylococcal shunt infections by continuous vancomycin prophylaxis. Am J Med Sci. 1971; 262(2):87-92. DOI: 10.1097/00000441-197108000-00003. View

3.
Esposito A, Gleckman R . Vancomycin. A second look. JAMA. 1977; 238(16):1756-7. DOI: 10.1001/jama.238.16.1756. View

4.
Mean F, Pellaton M, Magrini G . Study on the binding of dihydrotestosterone, testosterone and oestradiol with sex hormone binding globulin. Clin Chim Acta. 1977; 80(1):171-80. DOI: 10.1016/0009-8981(77)90276-5. View

5.
Ayus J, Eneas J, Tong T, Benowitz N, Schoenfeld P, Hadley K . Peritoneal clearance and total body elimination of vancomycin during chronic intermittent peritoneal dialysis. Clin Nephrol. 1979; 11(3):129-32. View